However, the application of P-MSCs largely reversed the markers related to podocyte injury and PINK1/Parkin-mediated mitophagy (Figure 8A–C), meaning that P-MSCs could alleviate podocyte injury and PINK1/Parkin-mediated mitophagy inhibition in DKD rats. This evidence concerns the gene PRKN and diabetic kidney disease.